MCHP
43
-3
AIZ
80
-2
COP
48
-2
EXR
48
2
JNJ
57
3
DVN
32
3
SE
71
-3
HCA
59
2
IBM
55
-2
DLTR
40
-3
FITB
58
2
STZ
43
-4
ALL
64
-12
AN
38
-2
GIS
57
-3
CFG
58
2
FOXA
53
-2
UAL
47
-4
TSN
48
-2
FSLR
32
-2
MCHP
43
-3
AIZ
80
-2
COP
48
-2
EXR
48
2
JNJ
57
3
DVN
32
3
SE
71
-3
HCA
59
2
IBM
55
-2
DLTR
40
-3
FITB
58
2
STZ
43
-4
ALL
64
-12
AN
38
-2
GIS
57
-3
CFG
58
2
FOXA
53
-2
UAL
47
-4
TSN
48
-2
FSLR
32
-2
Financhill
Back

PubMatic Vs. Ascendis Pharma AS Industry Stock Comparison

Sell
33

PUBM
PubMatic

Last Price:
$9.52
Seasonality Move:
0.04%
Sell
48

ASND
Ascendis Pharma AS

Last Price:
$166.13
Seasonality Move:
-9.72%
Sell
33
PubMatic (PUBM) is a Sell

Is PubMatic a Buy, Sell or Hold?

  • The current PubMatic [PUBM] share price is $9.42. The Score for PUBM is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • PUBM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $164.65. The Score for ASND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PUBM Stock Price Chart

What is PubMatic's stock price today?

  • The PubMatic share price today is $9.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PUBM is experiencing selling pressure, which indicates risk of future bearish movement.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $164.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.

PUBM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.54 Sell
Relative Strength Index (14 RSI): 26.06 Sell
Chaikin Money Flow: -202453 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.94 - 15.7) Sell
Bollinger Bands (100): (12.84 - 16.72) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.96 Buy
Relative Strength Index (14 RSI): 63.68 Buy
Chaikin Money Flow: -280747 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (135.08 - 160.62) Buy
Bollinger Bands (100): (124.26 - 145.68) Buy

PUBM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.63 Sell
20-day SMA: 11.89 Sell
50-day SMA: 13.87 Sell
200-day SMA: 16.38 Sell
8-day EMA: 9.89 Sell
20-day EMA: 11.41 Sell
50-day EMA: 13.24 Sell
200-day EMA: 15.65 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 154.01 Buy
20-day SMA: 153.39 Buy
50-day SMA: 139.38 Buy
200-day SMA: 134.63 Buy
8-day EMA: 157.06 Buy
20-day EMA: 151.09 Buy
50-day EMA: 143.18 Buy
200-day EMA: 134.95 Buy

PubMatic Earnings Growth & PUBM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.23 per share, and an increase next year of $0.23 per share.

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.82 per share, an increase next quarter of $0.04 per share, an increase this year of $3.21 per share, and an increase next year of $5.31 per share.

PubMatic Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):